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PROPOSITION Redistricting.

77

Initiative Constitutional Amendment.

PROPOSITION Discounts on Prescription Drugs.

78

Initiative Statute.

SUMMARY
Amends state Constitution’s process for redistricting
California’s Senate, Assembly, Congressional and Board
of Equalization districts. Requires three-member panel of
retired judges selected by legislative leaders. Fiscal Impact:
One-time state redistricting costs totaling no more than
$1.5 million and county costs in the range of $1 million.
Potential reduction in future costs, but net impact would
depend on decisions by voters.

SUMMARY
Establishes discount prescription drug program
for certain low- and moderate-income Californians.
Authorizes Department of Health Services to contract
with participating pharmacies for discounts and with
participating drug manufacturers for rebates. Fiscal
Impact: State costs for administration and outreach in the
millions to low tens of millions of dollars annually. State
costs for advance funding for rebates. Unknown potentially
significant savings for state and county health programs.

WHAT YOUR VOTE MEANS
YES
A YES vote on this measure
means: Boundaries for
political districts would be
drawn by retired judges
and approved by voters
at statewide elections. A
redistricting plan would be
developed for use following
the measure’s approval and
then following each future
federal census.

WHAT YOUR VOTE MEANS
YES
A YES vote on this measure
means: A new state drug
discount program would be
created to reduce the costs
that certain residents of the
state, including persons in
families with an income at
or below 300 percent of the
federal poverty level, would
pay for prescription drugs
purchased at pharmacies.

ARGUMENTS
PRO
PROPOSITION
77
MAKES
POLITICIANS
ACCOUNTABLE TO THE
PEOPLE. Yes on Prop. 77
guarantees fair, competitive
elections by ensuring voters
have the final say on voting
districts—not politicians.
Prop. 77 reduces special
interest influence and holds
politicians accountable to
their constituents. Fair
Districts, Real Competition
—Yes on 77.

NO
A NO vote on this measure
means: Boundaries for
political districts would
continue to be drawn
by the Legislature and
approved by the Governor.
A redistricting plan would
be developed following
each future federal census.

CON
Sponsors want you to believe
Prop. 77 makes government
better. Don’t be fooled! Read
the fine print: Voters lose their
right to reject redistricting
before it becomes effective;
politicians pick judges to draw
districts for them; it costs
taxpayers millions; and is
cemented into our Constitution.
Vote No on 77!

FOR ADDITIONAL INFORMATION
AGAINST
FOR
Californians for Fair
Edward J. Costa
Representation—No on 77
People’s Advocate
1127 11th Street, Suite 950
3407 Arden Way
Sacramento, CA 95814
Sacramento, CA 95825
(916) 448-7724
(916) 482-6175
emily@peoplesadvocate.org www.noonproposition77.com
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ARGUMENTS
PRO
Proposition 78 provides that
millions of seniors and low
income, uninsured Californians
can buy prescription drugs at
discounts of 40%. Adapted
from a successful program
operating in Ohio, Prop. 78
can take effect immediately
without a big government
bureaucracy.
Seniors,
taxpayers, nurses, doctors,
and patient advocates say
Yes on Proposition 78.
www.calrxnow.org

NO
A NO vote on this measure
means: The state would not
expand its drug discount
program beyond an existing
state program that assists
elderly and disabled persons
on Medicare.

CON
SPONSORED BY THE
PRESCRIPTION
DRUG
COMPANIES, Prop. 78
is a SMOKESCREEN to
stop Prop. 79, a real,
enforceable plan backed by
consumer groups. Under
the “voluntary” Prop. 78,
drug companies don’t have
to provide a single discount,
and the plan can END AT
ANY TIME. VOTE NO on
Prop. 78.

FOR ADDITIONAL INFORMATION
AGAINST
FOR
Anthony Wright
Californians for
Health Access California
Affordable Prescriptions
414 13th Street, Suite 450
1415 L Street, Suite 1250
Oakland, CA 94612
Sacramento, CA 95814
(510) 873-8787
info@calrxnow.org
awright@health-access.org
www.calrxnow.org
www.VoteNoOnProp78.com

PROPOSITION

78

DISCOUNTS ON PRESCRIPTION DRUGS.
INITIATIVE STATUTE.

Official Title and Summary

Prepared by the Attorney General

D  P D. I S.
• Establishes discount prescription drug program, overseen by California Department of Health Services.
• Enables certain low- and moderate-income California residents to purchase prescription drugs at
reduced prices.
• Authorizes Department: to contract with participating pharmacies to sell prescription drugs at agreed-upon
discounts negotiated in advance; to negotiate rebate agreements with participating drug manufacturers.
• Imposes $15 annual application fee.
• Creates state fund for deposit of drug manufacturers’ rebate payments.
• Requires Department’s prompt determination of residents’ eligibility, based on listed qualifications.
• Permits outreach programs to increase public awareness.
• Allows program to be terminated under specified conditions.

Summary of Legislative Analyst’s Estimate of Net State and Local
Government Fiscal Impact:
• One-time and ongoing state costs, potentially in the millions to low tens of millions of dollars annually, for
administration and outreach activities for a new drug discount program. A significant share of these costs
would probably be borne by the state General Fund.
• State costs, potentially in the low tens of millions of dollars, to cover the funding gap between when drug
rebates are collected by the state and when the state pays funds to pharmacies for drug discounts provided
to consumers. Any such costs not covered through advance rebate payments from drug makers would be
borne by the state General Fund.
• Unknown potentially significant savings for state and county health programs due to the availability of drug
discounts.
• Potential unknown effects on state revenues and expenditures from changes in prices and quantities of
drugs sold in California.

ANALYSIS BY THE LEGISLATIVE ANALYST
Background
Prescription Drug Coverage. Currently, several state
and federal programs provide prescription drug
coverage to eligible individuals. The state’s Medi-Cal
Program, which is administered by the Department
of Health Services (DHS), provides prescription
drugs for low-income children and adults. The state’s
Managed Risk Medical Insurance Board administers
the Healthy Families Program, which provides
prescription drugs for children in low-income and
moderate-income families who do not qualify for
Medi-Cal.
Beginning January 2006, the federal government
will provide prescription drug coverage to persons
enrolled in Medicare, a federal health program for
elderly and disabled persons. (This would include
some persons enrolled in Medi-Cal who are also
enrolled in Medicare.) Various other programs
funded with state or federal funds also provide
assistance to help pay part or all of the cost of drugs
for specified individuals.

36 Title and Summary/Analysis

In addition, many Californians receive coverage
for prescription drugs through private insurance
that is purchased by individuals or provided by their
employer or the employer of a member of their
family.
Drug Discount Programs. California, a number
of other states, and private associations and drug
makers have established drug discount programs.
These programs help certain consumers, including
individuals who are not eligible for state and
federal programs that provide drug coverage,
purchase prescription drugs at reduced prices.
Current California law, for example, requires retail
pharmacies to sell prescription drugs at a discount
to elderly and disabled persons enrolled in Medicare
as a condition of a pharmacy’s participation in the
Medi-Cal Program.
Proposal
This proposition creates a new state drug discount
program to reduce the costs that certain residents of
the state would pay for prescription drugs purchased
at pharmacies. The major components of the measure
are outlined below.
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ANALYSIS BY THE LEGISLATIVE ANALYST (CONTINUED)
Discount Card Program. Under the new drug
discount program, eligible persons could obtain a
card that would qualify them for discounts on their
drug purchases at pharmacies. The program would
be open to California residents in families with an
income at or below 300 percent of the federal poverty
level—up to almost $29,000 a year for an individual
or about $58,000 for a family of four. Persons
enrolled in Medicare could obtain discount cards
for drugs not covered by Medicare. Persons could
not participate in the new drug discount program if
they receive their drug coverage from private health
insurance, from the Medi-Cal or Healthy Families
Programs, or from other public programs supported
with state or federal funding. Persons generally could
not obtain a drug discount card for at least three
months after leaving these private or public sources
of drug coverage.
The new drug discount program would be
administered by DHS, which could contract with
a private vendor for assistance. Participants would
enroll in the program by paying a $15 fee, and would
pay an annual renewal fee of the same amount.
Eligible persons could enroll or reenroll in the
program at any pharmacy, doctor’s office, or clinic,
which chose to participate in the drug discount
program. Applications and renewals could also be
handled through an Internet Web site or through
a telephone call center. The DHS would review
applications and mail the drug discount cards to
eligible persons, usually within four days.
The state would seek two types of discounts in order
to obtain lower prices for persons with the new drug
discount cards. First, pharmacies that voluntarily
chose to participate in the program would agree to
sell prescription drugs to cardholders at an agreed-upon
discount negotiated in advance with the state. In
addition, pharmacies would further discount the
price to reflect any rebates the state negotiated with
drug makers. (The pharmacies would subsequently
be reimbursed for this second type of discount with
rebates collected by the state from drug makers.)
The DHS could end the drug discount program
if it found there were insufficient discounts to make
the program work, if too few persons enrolled in the
program, or if DHS could not find a vendor to help
run the program.
Private Drug Discount Programs. The measure directs
DHS to implement agreements with drug discount
programs operated by drug makers and other private
groups so that the discount cards would automatically
provide consumers with access to the best discount
available to them for a particular drug purchase.

For text of Proposition 78 see page 66.

Outreach Efforts. The measure directs DHS to
conduct an outreach program to inform state
residents about the new drug discount program.
Related Provisions in Proposition 79. Proposition 79
on this ballot also establishes a new state drug discount
program. The key differences between Proposition 78
and Proposition 79 are shown in Figure 1.
The State Constitution provides that if a particular
provision of a proposition that has been approved
by the voters is in conflict with a particular provision
of another proposition approved by the voters,
only the provision in the measure with the higher
number of yes votes would take effect. Proposition 78
specifies that its provisions would go into effect in
their entirety, and that none of the provisions of a
competing measure such as Proposition 79 would take
effect, if Proposition 78 received the higher number
of yes votes.
Fiscal Effects
This measure could have a number of fiscal effects
on state and local government. We discuss several major
factors below that could result in costs or savings.
State Costs for Administration and Outreach Activities.
The DHS would incur significant startup costs, as
well as ongoing costs, for administrative and outreach
activities to implement the new drug discount
program created by this proposition.
This would include administrative costs to:
• Establish the new program, including any new
information technology systems that would be
needed for its operation.
• Operate the Internet Web site and the call center
to receive applications for drug discount cards.
• Process applications and renewals of drug discount
cards.
• Negotiate and collect rebates from drug
manufacturers and make advance rebate payments
to pharmacies.
• Coordinate the state’s drug discount program with
other private drug discount programs.
The state could also incur additional costs for the
proposed outreach activities, potentially including
costs for radio or television advertising, written
materials, and other promotional efforts to make
consumers aware of the drug discount program.
In the aggregate, these administrative and outreach
costs would probably range from the millions to
low tens of millions of dollars annually. The exact
fiscal effect would depend primarily on the extent of
outreach efforts and the number of consumers who
chose to participate in the drug discount program.

Analysis
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ANALYSIS BY THE LEGISLATIVE ANALYST (CONTINUED)
FIGURE 1
KEY DIFFERENCES BETWEEN PROPOSITIONS 78

AND

79

Proposition 78

Proposition 79

General eligibility
requirements

• California residents in families with an
income at or below 300 percent of the
federal poverty level. (About $29,000
annually for an individual and $58,000
for a family of four.)
• No such provision.

• California residents in families with an
income at or below 400 percent of the
federal poverty level. (About $38,000
annually for an individual and $77,000
for a family of four.)
• Also, persons in families with medical
expenses at or above 5 percent of their
family’s income.

Persons excluded
from coverage

• Persons with outpatient prescription
drug coverage through Medi-Cal,
Healthy Families, a third-party payer, or
a health plan or drug discount program
supported with state or federal funds
(except Medicare beneficiaries).
• Certain persons with drug coverage,
during the three-month period prior
to the month the person applied for a
drug discount card.

• Persons with outpatient prescription
drug coverage through Medi-Cal or
Healthy Families (except Medicare
beneficiaries).

Application and
renewal fee

• $15 per year.

• $10 per year.

Method of obtaining
rebates from drug
makers

• Negotiated with drug makers.
• No such provision.

• Negotiated with drug makers.
• Subject to federal approval, links new
drug discount program to Medi-Cal for
the purpose of obtaining rebates on
drugs.

Assistance to
business and labor
organizations

• No such provision.

• Establishes drug discount program
to assist certain business and labor
entities.

Prescription Drug
Advisory Board

• No such provision.

• Creates new nine-member panel to
review the access to and pricing of
drugs.

Lawsuits over drug
profiteering law

• No such provision.

• Changes state law to make it a civil
violation for a drug maker to engage in
profiteering from the sale of drugs.
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• No such provision.

PROPOSITION

78

Discounts on Prescription Drugs.
Initiative Statute.

ANALYSIS BY THE LEGISLATIVE ANALYST (CONTINUED)
These costs could be partly offset by (1) any funds
available for this purpose from a new special fund
created by this measure, (2) any private donations
received for this purpose, and (3) a portion of the
enrollment fees collected for the program. The
amount of donations that the state would receive on
an ongoing basis for outreach activities is unknown.
The amount of available special funds or the fee
revenues that would be collected by the state is also
unknown. In view of the above, it appears likely that a
significant share of the cost of this program would be
borne by the General Fund.
Costs for “Float.” This measure requires the state to
reimburse pharmacies for part of the amount that
they discounted their drugs. This reimbursement
reflects discounts for which the state receives rebates
from drug makers.
The reimbursement to pharmacies must be made
within two weeks after their claims are filed with
the state. However, drug makers are required by
the measure to pay rebates to the state on at least a
quarterly basis. This means that the state could, in
many cases, pay out rebates to pharmacies before
it actually collects the rebate funds from drug
makers. Moreover, any disputes that arise over the
actual amounts owed for rebates could further slow
payments of rebate funds by drug makers to the state.
This recurring gap in funding between when rebate
money is collected by the state and when the state has
to pay pharmacies is commonly referred to as float.
The cost of the float is unknown, but could amount
to the low tens of millions of dollars, depending
on the level of participation in the program. Float
costs would occur mainly in the early years of
implementing this new program. After the program
has been fully implemented, rebate funds collected
from drug makers should be largely sufficient to
reimburse pharmacies.
This measure permits the state to enter into
agreements with drug makers to collect some rebate

For text of Proposition 78 see page 66.

funds in advance. The amount of funding that the
state would receive through such advance payments
is unknown. Any float costs that exceeded these
advance rebate payments would be borne by the state
General Fund.
Potential Savings for State and County Health
Programs. The drug discount program established
under this proposition could reduce costs to the state
and counties for health programs.
Absent the discounts available under such a drug
discount program, some lower-income individuals
who lack drug coverage might forego the purchase
of their prescribed drugs. Such individuals might
eventually require hospitalization as a result of their
untreated medical conditions, thereby adding to
Medi-Cal Program costs. Other individuals might
“spend down” their financial assets on expensive drug
purchases absent such discounts and become eligible
for Medi-Cal. The exact amount of savings to the
Medi-Cal Program from a drug discount program
is unknown, but could be significant if the program
enrolled a large number of consumers.
Similarly, the availability of a drug discount
program could reduce costs for other state health
programs. It could also do so for county indigent care
by decreasing out-of-pocket drug expenses for
low-income persons who require medications, thereby
making them less likely to rely on county hospitals or
clinics for assistance. The extent of these potential
savings is unknown.
Other Fiscal Effects. This measure would affect
both the prices and quantities of prescription drugs
sold in California. In turn, this could affect taxable
profits of drug makers and businesses that provide
health care for their employees, as well as consumers’
disposable income. These changes could affect state
revenues. Changes in the prices and quantities of
drugs sold could affect state expenditures as well.
The net impact of these factors on state revenues and
expenditures is unknown.

Analysis
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Argument in Favor of Proposition 78
Proposition 78 offers Californians struggling with high
prescription drug costs real help, right now. Prop. 78 is a
proven program that can take effect immediately, and will
deliver critically needed prescription drug discounts to
millions of seniors and low income, uninsured Californians.
Known as Cal Rx, Proposition 78 offers Californians the
best prescription drug discount program in the country.
It is an improved version of a successful program already
operating in Ohio that is delivering discounts averaging
31%, saving consumers $15.31 on every covered prescription.
Every major prescription drug manufacturer participates in
the Ohio program.
“This program is a lifesaver. My family saves $150 a
month on prescription drugs for my husband’s heart
condition. For us, it’s a miracle.”
Robin Ford, Canton, Ohio
Proposition 78 is even better than the Ohio program. The
California Department of Health Services concludes that
the Cal Rx program enacted by Proposition 78 will result in
discounts of over 40% to millions of eligible Californians.
State officials say that Cal Rx prices will compare favorably to
prices in Canada.
Here’s how Proposition 78 works:
• The program covers seniors and the uninsured with family
incomes up to $58,000 annually.
• Manufacturers will provide prescription drugs to the
Cal Rx program at the lowest commercial price they sell
to anyone in California and pharmacists will provide
additional discounts. According to state officials, the
average discount will be at least 40% off regular retail
prices.
• Prop. 78 also makes it easier for people to get access to
new and existing free drug programs, meaning even more
savings for consumers.
• Enrollment is simple. People can sign up at their local
pharmacy.

• Prop. 78 does not require a big government bureaucracy
to implement. The discounts go right to the patient in
their community.
• ALL drugs are eligible for discounts under Proposition 78,
not just those on a government determined list.
“Proposition 78 offers real hope to millions of
Californians who currently don’t have access to
affordable prescription medications. We want all
Californians in need to have access to prescription
medications and Proposition 78 will do that.”
Rick Roberts, HIV/AIDS Patient and Activist
Proposition 78 enjoys bipartisan support. It is supported
by groups representing seniors, patients, taxpayers, and small
businesses across the state. A Los Angeles Times news report
found Prop. 78, “would offer one of the most extensive
discounts in the country.”
Proposition 78 will bring real help, right now. It can go
into effect immediately and begin delivering deep discounts
on prescription drugs, helping millions of seniors and low
income, uninsured Californians.
There are two prescription drug discount proposals on the
ballot, but only Proposition 78 will work. Unlike the other
proposal, Prop. 78 doesn’t require federal approval, provides
discounts on a wider range of drugs, doesn’t depend on a
big government bureaucracy to be implemented, and won’t
result in costly litigation by trial lawyers.
Please, join seniors, taxpayers, consumers, patient
advocates, health care professionals, and small businesses,
and VOTE YES on Proposition 78.
KRISTINE YAHN, RN, Executive Director
Californians for Patient Care
CAROLYN PETERSON, RN, MS, AOCN
Chief Operating Officer
Community Hospice
DORIS LUNA, RN, Certified Pediatric Oncology Nurse
UC Davis Medical Center

Rebuttal to Argument in Favor of Proposition 78
Why are Californians struggling with high drug prices?
Because the drug companies funding Prop. 78 charge high
prices.
If drug companies want to offer discounts voluntarily, they can do
it today, without an initiative, without a new program.
• Prop. 78 provides smaller discounts to fewer people and
does not allow the state to enforce the discounts. This
approach already failed in California.
• Prop. 79 builds on existing efforts that have saved
taxpayers billions. It gives more middle and low income
Californians bigger discounts that can be enforced.
PROP. 78 USES AN APPROACH THAT HAS FAILED IN
CALIFORNIA AND ELSEWHERE
In 2001, California created the Golden Bear State
Pharmacy which relied on drug companies to voluntarily
lower their prices. The state shut it down because very few
drug companies agreed to participate.
Prop. 78 uses the same failed approach.

40 Arguments

PROP. 78: SMALLER DISCOUNTS, FEWER PEOPLE, NO
ENFORCEMENT
Drug companies face no penalty under Prop. 78 if they fail to
provide discounts and the industry can shut down Prop. 78 at
any time by failing to participate. Prop. 78 does not require
any, much less all, drugs to be discounted, and it offers
smaller discounts to fewer people.
DON’T BE FOOLED: If Prop. 78 gets more votes than Prop.
79, drug companies win and Californians lose.
That’s why drug companies contributed more than $50
million to pass Prop. 78 and defeat Prop. 79. That’s why
consumers, seniors, unions, nurses, and doctors say VOTE
NO on 78 and YES on 79.
BARBARA A. BRENNER, Executive Director
Breast Cancer Action
RAMÓN CASTELLBLANCH, Policy Advisor
Senior Action Network
KATHY J. SACKMAN, RN, President
United Nurses Association of California

Arguments printed on this page are the opinions of the authors and have not been checked for accuracy by any official agency.
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Argument Against Proposition 78
THE DRUG LOBBY IS SPENDING HISTORIC
AMOUNTS TO BLOCK THE REAL SOLUTION FOR FAIR
DRUG PRICES
Prop. 78 is a smokescreen designed and bankrolled with
tens of millions of dollars from the prescription drug lobby
to block Prop. 79, a real discount solution put forward by
consumer, health, and senior groups. Under their cynical
strategy, if both measures get a majority, the one with more votes
becomes law.
Newspapers report that just one contribution from
GlaxoSmithKline for $8.5 million could be “the largest ever
from a corporation to a California campaign.” Drug companies
donated $50 million to Prop. 78 by mid-July, on track to run what
could be the most expensive initiative campaign in California
history.
Jan Faiks, VP with PhRMA, the industry’s lobbying
arm, told the Los Angeles Times “the industry would spend
‘whatever it takes’ to defeat [Prop. 79].”
PROP. 78 RELIES ON MANUFACTURERS TO
VOLUNTEER DISCOUNTS: A PLAN PROVEN TO FAIL
Prop. 78 relies on drug manufacturers to voluntarily lower
their prices and does not allow the state of California to
enforce the program.
California tried this voluntary approach in 2001. The Golden
Bear State Pharmacy was designed to offer seniors voluntary
discounts on prescription medications. More than 500
drug manufacturers were invited to participate, yet only
14 agreed. Unable to implement it successfully, Governor
Schwarzenegger closed the program.
According to news reports, the drug companies said they
didn’t participate in Golden Bear because if they did, they
would have to give the federal government the same rebates
they were giving California seniors. Have they really changed
their minds four years later? Can we trust the manufacturers
to voluntarily lower their prices now? No.

PROP. 78’S DISCOUNTS CAN END AT ANY TIME
The drug lobby buried a provision in Prop. 78 that allows
them to effectively close their discount program when too
few manufacturers voluntarily lower their prices.
As stated in their initiative, Prop. 78 could end at any time
if there are too few participating manufacturers, or insufficient
discounts, or too few participating consumers.
Make no mistake, this provision was included by the drug
companies so they can end the program at any time and
protect their profit margins.
FEWER PEOPLE ARE ELIGIBLE, DISCOUNTS ARE LESS
Half as many Californians are eligible for discounts under Prop.
78 as under Prop. 79. Prop. 78 provides no discounts to many
uninsured Californians, those with catastrophic medical bills,
and the chronically ill such as cancer and diabetes patients
with inadequate drug coverage.
The discounts offered by Prop. 78 are based on the
“lowest commercial price” set by the drug companies. These
discounts could be anywhere from 15 to 40 percent—
significantly less than Prop. 79’s discounts.
VOTE NO on PROP. 78, a smokescreen by the
pharmaceutical industry to block the real solution to high
prices.
Instead, VOTE YES on PROP. 79 for fair prescription drug
prices.
NANCY J. BRASMER, President
California Alliance for Retired Americans
RICHARD HOLOBER, Executive Director
Consumer Federation of California
JACQUELINE JACOBBERGER, President
League of Women Voters of California

Rebuttal to Argument Against Proposition 78
Proposition 78 is based on a successful Ohio program
that delivers big discounts to consumers. Every major drug
manufacturer participates in Ohio. Proposition 78 is an
improved version of Ohio’s program and will produce even
larger discounts.
Even opponents admit that Proposition 78 could result
in 40% discounts for consumers. Because it is adapted
from a program already in operation, Proposition 78 won’t
be subject to lengthy court challenges. Unlike Prop. 79,
Proposition 78 doesn’t need federal government approval.
Prop. 78 can take effect immediately, helping millions of
seniors and low income, uninsured Californians get relief
from high prescription drug costs.
The comparison to the Golden Bear program is
misleading. That program was flawed, couldn’t be
implemented under federal rules to give Californians the
largest discounts possible, and was abandoned by the state.
Proposition 78 was written to FIX that problem.
This year, the Schwarzenegger administration, working
with leading Democrats, came together in the Legislature to
support the Cal Rx program contained in Proposition 78.

Had some legislators not succumbed to pressure from
special interest groups and defeated Cal Rx in the Legislature,
Californians would already be getting drug discounts.
Opponents falsely claim Proposition 78 can be abolished
by drug companies. ONLY THE STATE can end the program
if, for example, federal law changes and a new program
becomes available that is better for Californians.
Proposition 78 is supported by dozens of groups
representing seniors, taxpayers, small businesses, consumers,
health care advocates, and patient groups. It offers millions
of Californians real help, right now on prescription drug
prices. Vote YES on Proposition 78.
TOM MURPHY, Chair
California Arthritis Foundation Council
RUSTY HAMMER, President
Los Angeles Area Chamber of Commerce
JAMES S. GRISOLIA, M.D., Senior Vice President
Epilepsy Foundation of San Diego County

Arguments printed on this page are the opinions of the authors and have not been checked for accuracy by any official agency. Arguments
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TEXT OF PROPOSED LAWS

(PROPOSITION 77 CONTINUED)

(k) Except for judicial decrees, the provisions of this article are
the exclusive means of adjusting the boundary lines of the districts
specified herein.
Section 2. (a) Each member of the Senate, Assembly, Congress,
and the Board of Equalization shall be elected from a single-member
district. Districts of each type shall be numbered consecutively
commencing at the northern boundary of the State and ending at the
southern boundary.
(b) The population of all districts of a particular type shall be
as nearly equal as practicable. For congressional districts, the
maximum population deviation between districts shall not exceed
federal constitutional standards. For state legislative and Board of
Equalization districts, the maximum population deviation between
districts of the same type shall not exceed one percent or any stricter
standard required by federal law.
(c) Districts shall comply with any additional requirements of
the United States Constitution and any applicable federal statute,
including the federal Voting Rights Act.
(d) Each Board of Equalization district shall be comprised of 10
adjacent Senate districts and each Senate district shall be comprised of
two adjacent Assembly districts.
(e) Every district shall be contiguous.
(f) District boundaries shall conform to the geographic boundaries
of a county, city, or city and county to the greatest extent practicable.
In this regard, a redistricting plan shall comply with these criteria in
the following order of importance: (1) create the most whole counties
possible, (2) create the fewest county fragments possible, (3) create
the most whole cities possible, and (4) create the fewest city fragments
possible, except as necessary to comply with the requirements of the
preceding subdivisions of this section.
(g) Every district shall be as compact as practicable except to the
extent necessary to comply with the requirements of the preceding
subdivisions of this section. With regard to compactness, to the extent
practicable a contiguous area of population shall not be bypassed to
incorporate an area of population more distant.
(h) No census block shall be fragmented unless required to satisfy
the requirements of the United States Constitution.
(i) No consideration shall be given as to the potential effects on
incumbents or political parties. No data regarding the residence of an
incumbent or of any other candidate or the party affiliation or voting
history of electors may be used in the preparation of plans, except as
required by federal law.
Section 3. Any action or proceeding alleging that a plan adopted
by the Special Masters does not conform with the requirements of
this article must be filed within 45 days of the filing of the plan with

PROPOSITION 78
This initiative measure is submitted to the people in accordance with
the provisions of Article II, Section 8, of the California Constitution.
This initiative measure adds sections to the Health and Safety Code;
therefore, new provisions proposed to be added are printed in italic type
to indicate that they are new.

PROPOSED LAW
SECTION 1. FINDINGS AND DECLARATION OF PURPOSE
The people of the State of California do hereby fi nd and declare that:
(a) Prescription drugs are an integral part to managing acute and
chronic illness improving quality of life; and
(b) Prescription drugs are a convenient, cost-effective alternative to
more costly medical interventions; and
(c) Increasing the affordability and access of prescription medicines
will significantly improve health care quality and lower overall health
care costs.
SEC. 2. CALIFORNIA STATE PHARMACY ASSISTANCE
PROGRAM (CAL RX)
Division 112 (commencing with Section 130600) is added to the
Health and Safety Code, to read:
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the Secretary of State or such action or proceeding is forever barred.
Judicial review of the conformity of any plan with the requirements of
this article may be pursuant to a petition for extraordinary relief. If
any court finds a plan to be in violation of this article, it may order
that a new plan be adopted by a panel of Special Masters pursuant to
this article. A court may order any remedy necessary to effectuate
this article.
In the year following the year in which the national census is taken
under the direction of Congress at the beginning of each decade, the
Legislature shall adjust the boundary lines of the Senatorial, Assembly,
Congressional, and Board of Equalization districts in conformance
with the following standards:
(a) Each member of the Senate, Assembly, Congress, and the Board
of Equalization shall be elected from a single/member district.
(b) The population of all districts of a particular type shall be
reasonably equal.
(c) Every district shall be contiguous.
(d) Districts of each type shall be numbered consecutively
commencing at the northern boundary of the State and ending at the
southern boundary.
(e) The geographical integrity of any city, county, or city and
county, or of any geographical region shall be respected to the extent
possible without violating the requirements of any other subdivision of
this section.
SECTION 3. Severability
If any provision of this measure or the application thereof to any
person or circumstance is held invalid, including, but not limited to,
subdivision (b) of Section 1 of Article XXI, that invalidity shall not
affect other provisions or applications which can reasonably be given
effect in the absence of the invalid provision or application.
SECTION 4. Confl icting Ballot Measures
(a) In the event that this measure and another measure or measures
relating to the redistricting of Senatorial, Assembly, Congressional,
or Board of Equalization districts is approved by a majority of voters
at the same election, and this measure receives a greater number
of affi rmative votes than any other such measure or measures, this
measure shall control in its entirety and said other measure or measures
shall be rendered void and without any legal effect. If this measure is
approved but does not receive a greater number of affi rmative votes
than said other measure or measures, this measure shall take effect to
the extent permitted by law.
(b) If this measure is approved by voters but superseded by law by
any other confl icting ballot measure approved by the voters at the same
election, and the confl icting ballot measure is later held invalid, this
measure shall be self-executing and given full force of law.

DIVISION 112.

CALIFORNIA STATE PHARMACY ASSISTANCE
PROGRAM (CAL RX)
CHAPTER 1. GENERAL PROVISIONS
130600. This division shall be known, and may be cited, as the
California State Pharmacy Assistance Program or Cal Rx.
130601. For the purposes of this division, the following definitions
shall apply:
(a) “Benchmark price” means the price for an individual drug or
aggregate price for a group of drugs offered by a manufacturer equal to
the lowest commercial price for the individual drug or group of drugs.
(b) “Cal Rx” means the California State Pharmacy Assistance
Program.
(c) “Department” means the State Department of Health Services.
(d) “Fund” means the California State Pharmacy Assistance
Program Fund.
(e) “Inpatient” means a person who has been admitted to a hospital
for observation, diagnosis, or treatment and who is expected to remain
overnight or longer.
(f) (1) “Lowest commercial price” means the lowest purchase price
for an individual drug, including all discounts, rebates, or free goods,
available to any wholesale or retail commercial class of trade in California.
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(2) Lowest commercial price excludes purchases by government
entities, purchases pursuant to Section 340B of the federal Public
Health Services Act (42 U.S.C. Sec. 256b), or nominal prices as defined
in federal Medicaid drug rebate agreements.
(3) A purchase price provided to an acute care hospital or acute
care hospital pharmacy may be excluded if the prescription drug is used
exclusively for an inpatient of the hospital.
(4) Wholesale or retail commercial class of trade includes
distributors, retail pharmacies, pharmacy benefit managers, health
maintenance organizations, or any entities that directly or indirectly sell
prescription drugs to consumers through licensed retail pharmacies,
physician offices, or clinics.
(g) “Manufacturer” means a drug manufacturer as defined in
Section 4033 of the Business and Professions Code.
(h) “Manufacturer’s rebate” means the rebate for an individual
drug or aggregate rebate for a group of drugs necessary to make the
price for the drug ingredients equal to or less than the applicable
benchmark price.
(i) “Prescription drug” means any drug that bears the legend
“Caution: federal law prohibits dispensing without prescription,”
“Rx only,” or words of similar import.
(j) “Private discount drug program” means a prescription drug
discount card or manufacturer patient assistance program that provides
discounted or free drugs to eligible individuals. For the purposes of this
division, a private discount drug program is not considered insurance
or a third-party payer program.
(k) “Recipient” means a resident that has completed an application
and has been determined eligible for Cal Rx.
(l) “Resident” means a California resident pursuant to Section 17014
of the Revenue and Taxation Code.
(m) “Third-party vendor” means a public or private entity with
whom the department contracts pursuant to subdivision (b) of Section
130602, which may include a pharmacy benefit administration or
pharmacy benefit management company.
130602. (a) There is hereby established the California State
Pharmacy Assistance Program or Cal Rx.
(b) The department shall provide oversight of Cal Rx. To implement
and administer Cal Rx, the department may contract with a thirdparty vendor or utilize existing health care service provider enrollment
and payment mechanisms, including the Medi-Cal program’s fiscal
intermediary.
(c) Any resident may enroll in Cal Rx if determined eligible pursuant
to Section 130605.
CHAPTER 2. ELIGIBILITY AND APPLICATION PROCESS
130605. (a) To be eligible for Cal Rx, an individual shall meet all of
the following requirements at the time of application and reapplication
for the program:
(1) Be a resident.
(2) Have family income, as reported pursuant to Section 130606,
that does not exceed 300 percent of the federal poverty guidelines, as
revised annually by the United States Department of Health and Human
Services in accordance with Section 673(2) of the Omnibus Budget
Reconciliation Act of 1981 (42 U.S.C. Sec. 9902), as amended.
(3) Not have outpatient prescription drug coverage paid for in whole
or in part by any of the following:
(A) A third-party payer.
(B) The Medi-Cal program.
(C) The children’s health insurance program.
(D) The disability medical assistance program.
(E) Another health plan or pharmacy assistance program that uses
state or federal funds to pay part or all of the cost of the individual’s
outpatient prescription drugs. Notwithstanding any other provision of
this division to the contrary, an individual enrolled in Medicare may
participate in this program, to the extent allowed by federal law, for
prescription drugs not covered by Medicare.
(4) Not have had outpatient prescription drug coverage specified in
paragraph (3) during any of the three months preceding the month in
which the application or reapplication for Cal Rx is made, unless any of
the following applies:

(A) The third-party payer that paid all or part of the coverage filed
for bankruptcy under the federal bankruptcy laws.
(B) The individual is no longer eligible for coverage provided
through a retirement plan subject to protection under the Employee
Retirement Income Security Act of 1974 (29 U.S.C. Sec. 1001),
as amended.
(C) The individual is no longer eligible for the Medi-Cal program,
children’s health insurance program, or disability medical assistance
program.
(b) Application and an annual reapplication for Cal Rx shall be
made pursuant to subdivision (d) of Section 130606. An applicant, or a
guardian or custodian of an applicant, may apply or reapply on behalf
of the applicant and the applicant’s spouse and children.
130606. (a) The department or third-party vendor shall develop an
application and reapplication form for the determination of a resident’s
eligibility for Cal Rx.
(b) The application, at a minimum, shall do all of the following:
(1) Specify the information that an applicant or the applicant’s
representative must include in the application.
(2) Require that the applicant, or the applicant’s guardian or
custodian, attest that the information provided in the application
is accurate to the best knowledge and belief of the applicant or the
applicant’s guardian or custodian.
(3) Include a statement printed in bold letters informing the
applicant that knowingly making a false statement is punishable under
penalty of perjury.
(4) Specify that the application and annual reapplication fee due
upon submission of the applicable form is fi fteen dollars ($15).
(c) In assessing the income requirement for Cal Rx eligibility,
the department shall use the income information reported on the
application and not require additional documentation.
(d) Application and annual reapplication may be made at any
pharmacy, physician office, or clinic participating in Cal Rx, through
a Web site or call center staffed by trained operators approved by the
department, or through the third-party vendor. A pharmacy, physician
office, clinic, or third-party vendor completing the application shall
keep the application fee as reimbursement for its processing costs. If it
is determined that the applicant is already enrolled in Cal Rx, the fee
shall be returned to the applicant and the applicant shall be informed of
his or her current status as a recipient.
(e) The department or third-party vendor shall utilize a secure
electronic application process that can be used by a pharmacy,
physician office, or clinic, by a Web site, by a call center staffed
by trained operators, or through the third-party vendor to enroll
applicants in Cal Rx.
(f) During normal hours, the department or third-party vendor shall
make a determination of eligibility within four hours of receipt by Cal
Rx of a completed application. The department or third-party vendor
shall mail the recipient an identification card no later than four days
after eligibility has been determined.
(g) For applications submitted through a pharmacy, the department
or third-party vendor may issue a recipient identification number for
eligible applicants to the pharmacy for immediate access to Cal Rx.
130607. (a) The department or third-party vendor shall attempt to
execute agreements with private discount drug programs to provide a
single point of entry for eligibility determination and claims processing
for drugs available in those private discount drug programs.
(b) (1) Private discount drug programs may require an applicant
to provide additional information, beyond that required by Cal Rx, to
determine the applicant’s eligibility for discount drug programs.
(2) An applicant shall not be, under any circumstances, required
to participate in, or to disclose information that would determine the
applicant’s eligibility to participate in, private discount drug programs
in order to participate in Cal Rx.
(3) Notwithstanding paragraph (2), an applicant may voluntarily
disclose or provide information that may be necessary to determine
eligibility for participation in a private drug discount program.
(c) For those drugs available pursuant to subdivision (a), the
department or third-party vendor shall develop a system that provides
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a recipient with the best prescription drug discounts that are available
to them through Cal Rx or through private discount drug programs.
(d) The recipient identification card issued pursuant to subdivision (g)
of Section 130606 shall serve as a single point of entry for drugs available
pursuant to subdivision (a) and shall meet all legal requirements for a
uniform prescription drug card pursuant to Section 1363.03.
CHAPTER 3. ADMINISTRATION AND SCOPE
130615. (a) To the extent that funds are available, the department
shall conduct outreach programs to inform residents about Cal Rx and
private drug discount programs available through the single point of
entry as specified in subdivisions (a) and (d) of Section 130607. No
outreach material shall contain the name or likeness of a drug. The name
of the organization sponsoring the material pursuant to subdivision (b)
may appear on the material once and in a font no larger than 10 point.
(b) The department may accept on behalf of the state any gift,
bequest, or donation of outreach services or materials to inform
residents about Cal Rx. Neither Section 11005 of the Government Code,
nor any other law requiring approval by a state officer of a gift, bequest,
or donation shall apply to these gifts, bequests, or donations. For
purposes of this section, outreach services may include, but shall not be
limited to, coordinating and implementing outreach efforts and plans.
Outreach materials may include, but shall not be limited to, brochures,
pamphlets, fliers, posters, advertisements, and other promotional items.
(c) An advertisement provided as a gift, bequest, or donation
pursuant to this section shall be exempt from Article 5 (commencing
with Section 11080) of Chapter 1 of Part 1 of Division 3 of Title 2 of the
Government Code.
130616. (a) Any pharmacy licensed pursuant to Article 7
(commencing with Section 4110) of Chapter 9 of Division 2 of the
Business and Professions Code may participate in Cal Rx.
(b) Any manufacturer, as defined in subdivision (g) of Section
130601, may participate in Cal Rx.
130617. (a) This division shall apply only to prescription drugs
dispensed to noninpatient recipients.
(b) The amount a recipient pays for a drug within Cal Rx shall be
equal to the pharmacy contract rate pursuant to subdivision (c), plus
a dispensing fee that shall be negotiated as part of the rate pursuant to
subdivision (c), less the applicable manufacturer’s rebate.
(c) The department or third-party vendor may contract with
participating pharmacies for a rate other than the pharmacist’s usual
and customary rate. However, the department must approve the
contracted rate of a third-party vendor.
(d) The department or third-party vendor shall provide a claims
processing system that complies with all of the following requirements:
(1) Charges a price that meets the requirements of subdivision (b).
(2) Provides the pharmacy with the dollar amount of the discount to
be returned to the pharmacy.
(3) Provides a single point of entry for access to private discount
drug programs pursuant to Section 130607.
(4) Provides drug utilization review warnings to pharmacies
consistent with the drug utilization review standards outlined in Section
1927 of the federal Social Security Act (42 U.S.C. Sec. 1396r–8(g)).
(e) The department or third-party vendor shall pay a participating
pharmacy the discount provided to recipients pursuant to subdivision
(b) by a date that is not later than two weeks after the claim is received.
(f) The department or third-party vendor shall develop a program to
prevent the occurrence of fraud in Cal Rx.
(g) The department or third-party vendor shall develop a mechanism
for recipients to report problems or complaints regarding Cal Rx.
130618. (a) In order to secure the discount required pursuant to
subdivisions (b) and (c) of Section 130617, the department or thirdparty vendor shall attempt to negotiate drug rebate agreements for
Cal Rx with drug manufacturers.
(b) Each drug rebate agreement shall do all of the following:
(1) Specify which of the manufacturer’s drugs are included in the
agreement.
(2) Permit the department to remove a drug from the agreement in
the event of a dispute over the drug’s utilization.
(3) Require the manufacturer to make a rebate payment to the
department for each drug specified under paragraph (1) dispensed to
a recipient.
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(4) Require the rebate payment for a drug to be equal to the amount
determined by multiplying the applicable per unit rebate by the number
of units dispensed.
(5) Define a unit, for purposes of the agreement, in compliance
with the standards set by the National Council of Prescription Drug
Programs.
(6) Require the manufacturer to make the rebate payments to the
department on at least a quarterly basis.
(7) Require the manufacturer to provide, upon the request of the
department, documentation to validate that the per unit rebate provided
complies with paragraph (4).
(8) Permit a manufacturer to audit claims for the drugs the
manufacturer provides under Cal Rx. Claims information provided to
manufacturers shall comply with all federal and state privacy laws that
protect a recipient’s health information.
(c) To obtain the most favorable discounts, the department may limit
the number of drugs available within Cal Rx.
(d) The entire amount of the drug rebates negotiated pursuant to this
section shall go to reducing the cost to Cal Rx recipients of purchasing
drugs. The Legislature shall annually appropriate an amount to cover
the state’s share of the discount provided by this section.
(e) The department or third-party vendor may collect prospective
rebates from manufacturers for payment to pharmacies. The amount
of the prospective rebate shall be contained in drug rebate agreements
executed pursuant to this section.
(f) Drug rebate contracts negotiated by the third-party vendor
shall be subject to review by the department. The department may
cancel a contract that it finds not in the best interests of the state or
Cal Rx recipients.
(g) The third-party vendor may directly collect rebates from
manufacturers in order to facilitate the payment to pharmacies
pursuant to subdivision (e) of Section 130617. The department shall
develop a system to prevent diversion of funds collected by the thirdparty vendor.
130619. (a) The department or third-party vendor shall generate a
monthly report that, at a minimum, provides all of the following:
(1) Drug utilization information.
(2) Amounts paid to pharmacies.
(3) Amounts of rebates collected from manufacturers.
(4) A summary of the problems or complaints reported regarding
Cal Rx.
(b) Information provided in paragraphs (1), (2), and (3) of
subdivision (a) shall be at the national drug code level.
130620. (a) The department or third-party vendor shall deposit all
payments received pursuant to Section 130618 into the California State
Pharmacy Assistance Program Fund, which is hereby established in the
State Treasury.
(b) Notwithstanding Section 13340 of the Government Code, moneys
in the fund are hereby appropriated to the department without regard
to fiscal years for the purpose of providing payment to participating
pharmacies pursuant to Section 130617 and for defraying the costs of
administering Cal Rx. Notwithstanding any other provision of law, no
money in the fund is available for expenditure for any other purpose or for
loaning or transferring to any other fund, including the General Fund.
130621. The department may hire any staff needed for the
implementation and oversight of Cal Rx.
130622. The department shall seek and obtain confirmation from
the federal Centers for Medicare and Medicaid Services that Cal Rx
complies with the requirements for a state pharmaceutical assistance
program pursuant to Section 1927 of the federal Social Security Act
(42 U.S.C. Sec. 1396r–8) and that discounts provided under the
program are exempt from Medicaid best price requirements.
130623. (a) Contracts and change orders entered into pursuant
to this division and any project or systems development notice shall be
exempt from all of the following:
(1) The competitive bidding requirements of State Administrative
Manual Management Memo 03-10.
(2) Part 2 (commencing with Section 10100) of Division 2 of the
Public Contract Code.
(3) Article 4 (commencing with Section 19130) of Chapter 5 of
Part 2 of Division 5 of Title 2 of the Government Code.
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(b) Change orders entered into pursuant to this division shall not
require a contract amendment.
130624. The department may terminate Cal Rx if the department
makes any one of the following determinations:
(a) That there are insufficient discounts to participants to make
Cal Rx viable.
(b) That there are an insufficient number of applicants for Cal Rx.
(c) That the department is unable to find a responsible third-party
vendor to administer Cal Rx.
130625. Notwithstanding Chapter 3.5 (commencing with Section
11340) of Part 1 of Division 3 of Title 2 of the Government Code, the
director may implement this division in whole or in part, by means of
a provider bulletin or other similar instructions, without taking
regulatory action.
SEC. 3. GENERAL PROVISIONS
(a) Conflicting Measures:
(1) This measure is intended to be comprehensive. It is the intent
of the people that in the event that this measure and another initiative
measure or measures relating to the same subject shall appear on the

same statewide election ballot, the provisions of the other measure or
measures shall be deemed to be in confl ict with this measure. In the
event that this measure shall receive a greater number of affi rmative
votes, the provisions of this measure shall prevail in their entirety, and
all provisions of the other measure or measures shall be null and void.
(2) If this measure is approved by voters but superseded by law by
any other conflicting ballot measure approved by the voters at the same
election, and the conflicting ballot measure is later held invalid, this
measure shall be self-executing and given full force of law.
(b) Severability: The provisions of this chapter are severable. If any
provision of this chapter or its application is held invalid, that invalidity
shall not affect other provisions or applications that can be given effect
without the invalid provision or application.
(c) Amendment: The provisions of this act may be amended by
a statute that is passed by a vote of two-thirds of the membership
of each house of the Legislature and signed by the Governor. All
amendments to this act shall be to further the act and shall be
consistent with its purposes.
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(3) “Qualified Californian” also means a resident of California who
has a family income equal to or less than 400 percent of the federal
poverty guidelines and who shall not have outpatient prescription drug
coverage paid for in whole or in part by the Medi-Cal program or the
Healthy Families Program.
(4) For purposes of this subdivision, the cost of drugs provided
under this division is considered an expense incurred by the family for
eligibility determination purposes.
(e) “Prescription drug” means any drug that bears the legend
“Caution: federal law prohibits dispensing without prescription,”
“Rx only,” or words of similar import.
CHAPTER 2. PRESCRIPTION DRUG DISCOUNTS
130510. (a) The amount a Cal Rx Plus participant pays for a drug
through the program shall be equal to the participating provider’s
usual and customary charge or the pharmacy contract rate pursuant to
subdivision (c), less a program discount for the specific drug or an average
discount for a group of drugs or all drugs covered by the program.
(b) In determining program discounts on individual drugs, the
department shall take into account the rebates provided by the drug’s
manufacturer and the state’s share of the discount.
(c) The department may contract with participating pharmacies for
a rate other than the pharmacies’ usual and customary rate.
130511. (a) The department shall negotiate drug rebate agreements
with drug manufacturers to provide for discounts for prescription drugs
purchased through Cal Rx Plus.
(b) Consistent with federal law, the department shall seek to contract
for drug rebates that result in a net price comparable to or lower than the
Medicaid best price for drugs covered by the program. The department
shall also seek to contract a net price comparable to or lower than the
price for prescription drugs provided to the federal government.
(c) To obtain the most favorable discounts, the department may limit
the number of drugs available through the program.
(d) No less than 95 percent of the drug rebates negotiated pursuant
to this section shall be used to reduce the cost of drugs purchased by
participants in the program.
(e) (1) Any pharmacy licensed pursuant to Chapter 9 (commencing
with Section 4000) of Division 2 of the Business and Professions Code
may participate in the program.
(2) Any drug manufacturer may participate in the program.
130512. (a) Subject to this section, the department may not
enter into a new contract or extend an existing contract with a drug
manufacturer for the Medi-Cal program if the drug manufacturer
will not provide Cal Rx Plus a rate comparable to or lower than the
Medicaid best price. This provision shall not apply to a drug for which
there is no therapeutic equivalent.
(b) To the extent permitted by federal law, the department may
require prior authorization in the Medi-Cal program for any drug of a
manufacturer that fails to agree to a price comparable to or lower than
the Medi-Cal best price for prescription drugs purchased under
this division.

This initiative measure is submitted to the people in accordance with
the provisions of Article II, Section 8, of the California Constitution.
This initiative measure adds sections to the Health and Safety Code;
therefore, new provisions proposed to be added are printed in italic type
to indicate that they are new.

PROPOSED LAW
CHEAPER PRESCRIPTION DRUGS FOR CALIFORNIA ACT
(CAL RX PLUS)
SECTION 1. Division 112 (commencing with Section 130500) is
added to the Health and Safety Code, to read:
DIVISION 112. CHEAPER PRESCRIPTION DRUGS
FOR CALIFORNIA ACT (CAL RX PLUS)
CHAPTER 1. GENERAL PROVISIONS
130500. This division shall be known, and may be cited, as the
Cheaper Prescription Drugs for California Program or Cal Rx Plus.
130501. The Cheaper Prescription Drugs for California Program,
or Cal Rx Plus, is established to reduce prescription drug prices and
to improve the quality of health care for residents of the state. The
program is administered by the State Department of Health Services
to use manufacturer rebates and pharmacy discounts to reduce
prescription drug prices for Californians.
130502. The people of California find that affordability is critical
in providing access to prescription drugs for California residents. This
program is enacted by the people to enable the state to take steps to make
prescription drugs more affordable for qualified California residents,
thereby increasing the overall health of California residents, promoting
healthy communities, and protecting the public health and welfare. It is
not the intention of the state to discourage employers from offering or
paying for prescription drug benefits for their employees or to replace
employer-sponsored prescription drug benefit plans that provide benefits
comparable to those made available to qualified California residents
under this program.
130503. Cal Rx Plus shall be available to Californians facing high
prescription drug costs to provide lower prescription drug prices. To
the extent permitted by federal law, Cal Rx Plus shall also be available
to small businesses and other entities, as defined, that provide health
coverage for Californians.
130504. For purposes of this division, the following definitions apply:
(a) “Department” means the State Department of Health Services.
(b) “Fund” means the Cal Rx Plus Program Fund.
(c) “Program” means the Cheaper Prescription Drugs for
California Program or Cal Rx Plus.
(d) (1) “Qualified Californian” means a resident of California
whose total unreimbursed medical expenses equal 5 percent or more of
family income.
(2) “Qualified Californian” also means an individual enrolled in
Medicare who may participate in this program, to the extent allowed by
federal law, for prescription drugs not covered by Medicare.
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